See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Aug. 8, 2003

Depression Breast Cancer Uterine Fibroids

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch

Depression

A clinical research trial of a medication that may help people who are having difficulty shaking persistent feelings of sadness.

Volunteers can range in age from 18-64 with a current episode of depression lasting 12 weeks or more and who have not been diagnosed with bi-polar disorder, anxiety or schizophrenia. Research site located in Lakewood, Washington.

More Information

Please see http://www.centerwatch.com/patient/studies/cat164.html.

-----

Breast Cancer

A study to determine the effectiveness of an oral drug for the treatment of metastatic breast cancer tumors that are known to overexpress the protein HER2/neu. Volunteers are needed with refractory stage IIIb or IV breast cancer and who have had no more than two prior regimens for metastatic breast cancer. Each regimen must have contained Herceptin. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat29.html.

-----

Uterine Fibroids

A research study of a medication for uterine fibroids. Pre-menopausal women at age 18-52 who have heavy uterine bleeding, chronic pelvic pressure, and bladder or bowel problems may be eligible to participate.

The research site is in San Diego.

More Information

Please see http://www.centerwatch.com/patient/studies/cat322.html.

-----

Copyright 2003 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.